Sleep Disordered Breathing And Craniofacial Growth And Development; Early Intervention And Patient Outcomes
Our second congress took place on March 1-5, 2017 at the Fairmont Chicago Millennium Park in Chicago, IL, USA
A word from our executive director and chairman
There is a whiff of history in the air. Never since the term “myofunctional therapy” was coined by Benno Lisher in the Harvard School of Dental Medicine’s Department of Orthodontics about 100 years ago has there been such a momentum of excitement, enthusiasm, passion, and research. Interest from governments looking to solve national public health issues, leading foundations working to solve health crises, and the world’s leading research universities have not only begun to take notice of orofacial myofunctional therapy (OMT), but have taken action. The AAMS was created in part to engender a scientific foundation upon which we will launch this emerging field of medicine and I am privileged to write that you will see some of that foundation being laid here this week in Chicago.
The enthusiasm for orofacial myofunctional therapy as I have travelled the globe has been has been never been more infectious. From Rome in May 2016 when the Italian Minister of Health issued a 27 page statement calling for OMT if pediatric OSA or snoring is suspected, from Singapore in October 2016 where the Asian Pediatric Pulmonary Society (APSS) adopted OMT as a standard of care for pediatric OSA, to Brazil where the “Frenum Inspection Law has been (mandating newborns to have their frenulum inspected and revised, if warranted, avoid orofacial myofunctional disorders (OMDs) throughout life) in effect now for 2 years, to Bethesda where OMT has a place at the table on NIH committees, and to major institutions such as Lurie Children’s Hospital in Chicago where myofunctional therapy is trained across the entire speech-language pathology faculty, to Stanford School of Medicine where leaders in sleep medicine and public health are asking how to change medical paradigms with a great sense of urgency to bring help as many patients as possible, there is a sense that we are on the cusp of great change.
We have much work to do to tell our story, and establish the science, standards, curricula, measurement, and regulations to protect and continue our growth to bring OMT to those who need it. This 2nd Congress’ presentations, has some of the best and brightest teams looking to help tell that story, and build that future. Late-breaking papers on the correlation of angkyloglossia and maxillary hypoplasia and proposals for new standards of care including OMT for orthognathic surgery, treatment for special needs populations, will not only be premiered here, but there will be discussion, debate, and design for practical means and tools for screening for OMDs across large populations to create awareness and deliver care.
You will see an AAMS Satellite Symposium: Research Priorities For Myofunctional Therapy: Action in Rehabilitation, Dentistry and Medicine: Findings from the 2nd AAMS Congress. Leaders on the cutting edge of their fields of care will join some of the foremost leaders leaders in their fields to explore priorities, focusing in on concrete steps that will catalyse OMT.
Last, but not least, the 2nd Hippocrates Gala on the 80th Floor of the Aon Building was a not miss occasion, where we celebrated 12 extraordinary leaders and 4 institutions for their mission, vision, and contribution to our field. The excitement is palpable as we are on the frontier of seeing OMT grow in leaps and bounds. It has been a great and humbling privilege to help
LIST OF SPEAKERS
Nicole Archambault Besson, MS, CCC-SLP | USA
Emotions and Executive Functions: Integrating the Limbic System and the Prefrontal Cortex in Myofunctional Therapy.
Rakesh Bhattacharjee, MD | USA
• Pediatric OSA, OMT & Obesity.
• A Call for OMT in Pediatric Hospital Care for Early OSA & Craniofacial Intervention.
Esther Bianchini, PhD | Brazil
Different approaches of Orofacial Myofunctional Therapy (OMT) in OSA patients.
Workshop: Myofunctional therapy, TMD and EMG
Eyal Botzer, DMD | Israel
Restricted lingual frenum-surgery and management.
Workshop: Surgical Techniques for Infant Frenotomies. A Practical Workshop Including Live Surgeries.
Kevin Boyd, MSc | USA
Pre-industrial fetal and infant/early Childhood Craniofacial Growth and Development.
James Bronson, DDS, FBPI | USA
Myofunctional Therapy and Early Orthodontic Intervention: What Can Be Done for 0-3 & 4-7 Populations: ALF & OMT.
Marlei Braude Canterji, MBG, SLP | Brazil
OMT With Morbid Obesity and Bariatric Surgery: A New Standard of Care.
Linda D’Onofrio, MS, CCC-SLP | USA
Teaching Oromyofunction & Articulation to Special Populations.
Robert Corruccini, PhD | USA
Implications of the Human Evolutionary Past for Facial Myofunctional Variation.
Michelle Emanuel, OTR/L | USA
Bringing Myofunctional Therapy to Precrawling Babies: Optimizing Oral Function and Posture from the First Breath.
Melania Evangelisti, MD, PhD | Italy
Standardized myofunctional exercises in children with sleep disordered breathing.
Mariana Evans, DMD | USA
Evolution of facial form and function with 3D CBCT documentation: A call to action!
Patrick Fellus, MD | France
From suction deglutition to swallowing deglutition by cortical or subcortical networks.
Thierry Gouzland, PT, OMT
Anatomical and functional score of the oro-facial system : presentation and interest in an interdisciplinary team. Using an Application.
David Gozal MD and Leila Gozal MD | USA
Myofunctional Therapy: What we know and what we need to know for it to be a standard of care across medicine.
Diana Grandi MS, SLP
Protocol for Detection of Snoring and Sleep Disordered Breathing in Adults
Christian Guilleminault MD, PhD | USA
A Case for Myofunctional Therapy As A Standard of Care for Pediatric OSA.
William Hang, DDS | USA
AIRWAY-kening (TM) Orthodontic and Myofunctional Therapy.
Alison Hazelbaker, PhD, IBCLC | USA
The Faux tie: When is Tongue-tie NOT a tongue-tie?
Miho Imamura PhD DDS | Japan
Myofunctional orthodontic treatment with MFT for the long term stability.
Bridget Ingle, RN, RM, IBCLC | Australia
Applying Myofunctional Support for the Breastfeeding Dyad.
Triin Jagomagi, PhD, MSc | Estonia
An Ideal Allied Team Model for Orthodontic, Craniofacial, and OSA Intervention: OMT Centered Care.
Sharon Keenan, PhD | USA
Workshop: Sleep Disorder Bootcamp.
Umakanth Khatwa, MD | USA
Treatment Modalities For Obstructive Sleep Disordered Breathing in Children: Challenges and Gaps.
Lawrence Kotlow, DDS | USA
Merging of medicine and dentistry in treating infants and toddlers.
Larry Kotlow, DDS and Scott A. Siegel, MD, DDS, FACS, FICS, FAAP
Workshop: Treatment of Tethered oral tissues using lasers. A comparison of different wavelengths and which laser is best for your type of practice.
Lois Laynee, PhD | USA
Creating the Brightest Future for Midline Anomalies.
Stanley Liu, MD, DDS | USA
• The Stanford Surgical Algorithm: A Frenum Surgery Standard Of Care
• Myofunctional Therapy and Sleep Surgery: New Standards of Care for MMA & and Hypoglossal Nerve Stimulation Surgeries
Darius Loghmanee, MD, FAAP, FAASM | USA
Moving Toward a Scalable Approach to Orofacial Myofunctional Screening and Treatment: Lessons from Population Sleep Health.
Derek Mahony, BDS, MscOrth | Australia
Eustachian Tube Disfunction and Tinnitus: A New Role for OMT.
Irene Marchesan, PhD SLP | Brazil
Application of myofunctional therapy in various fields of medicine.
Workshop: Restricted Lingual Frenum: Diagnosis and Management
Patrick McKeown, MA, BBE | Ireland.
The Critical Role of Myofunctional Therapy in Breathing: Performance Essentials.
Joy Moeller, RDH, BS | USA
• Myofunctional Approach for Children 0 to 5 years of Age.
• OMT & ENT Screening Tools: A Proposal for New Standards of Care in ENT Medicine.
Marc Moeller, BA | USA
Connecting Countries, Universities and Clinicians: Importance of Networking and Advocacy in Myofunctional Sciences.
Sharon Moore, BS | AUSTRALIA
Calling all Speech Pathologists: Sleep Disorders are in Your Face.
Maurice Ohayon, MD, PhD | USA
Myofunctional therapy and public health.
Judy Owens, MD | USA
Overview of Pediatric Sleep Related Breathing Disorders.
Maria Pia Villa, MD | Italy
• Frenum Evaluation in Children with and Without Sleep Disordered Breathing.
• Orthodontic treatment options and myofunctional therapy in children with SDB.
Barry Raphael, DDS | USA
Integrative Myofunctional Orthodontics: Mixed Modalities in Practice.
Nancy Rothstein, MBA | USA
Sleep: Essential for Health & Life.
Sabina Saccomanno, MD | Italy
• A Proposal for New Standards of Care in Orthodontics: Inclusion of OMT.
• Specific Myofunctional Therapy Protocol in Children with Down Syndrome.
Marisa Santos, DDS | Argentina
Early intervention in orofacial dysfunctions.
Ricardo Santos, PhD(c) | PORTUGAL
• New Protocols for the Screening of Myofunctional Disorders as Clinical Markers for OSA for SLPs.
• OMT within a larger public health context
Naurine Shaw, BDS, COM | Canada
Oral Muscle Dysfunction and Orthodontics.
Steven Sheldon, MD | USA
Biology of Adolescent Sleep: What if he’s not simply lazy?
Scott Siegel, MD, DDS, FACS
Treatment of Tethered oral tissues using lasers. A comparison of different wavelengths and which laser is best for your type of practice.
Valery Sinkus, PT | USA
Myofunctional Therapy, Frenum Release and Posture: The Critical Role of Fascia in OMT.
Corinne Thery-Dumeix, MD | France
Orthopedic treatment before the age of six on patients suffering from Sleep Disordered Breathing.
Marileda Tome, Phd, SLP | Brazil
Myofunctional Therapy as a Core Aspect of Speech Language Pathology.
Anastasia Vasileiu, DDS
Mouth Closed Campaign for Symmetrical and Healthy Children.
Pia Villanueva, PhD, DDS | Chile
Good Oral Habits Since Day One.
Heidi Widoff, RDH, COM | USA
Gingival Recession: Can Myofunctional Therapy make a difference?
Hideharu Yamaguchi, DDS | Japan
Malocclusion associated with abnormal Function and Habitual Posture- Researching for the clinical evidence.
Audrey Yoon, DDS, MS | USA
Ankyloglossia as a risk factor for maxillary hypoplasia.
Soroush Zaghi, MD | USA
• What is a “Sleep Surgeon”? How can I get the ENT’s or Oral Surgeons in my community to help my patients with sleep and frenulum disorders?
• Restrictive lingual frenulum as a phenotype for upper airway resistance syndrome and obstructive sleep apnea.
AAMS Second Hippocrates Award Gala
Celebrates our leaders who fight to make the world a better place, spotlighting distinguished achievement and fund raising objectives of the AAMS.
A nascent field is fragile. It needs stories and storytellers. It needs pioneers. It needs heroes. It needs champions. In the creation of the 1st AAMS Hipppocrates Awards given in Rome in 2014 (and since in Los Angeles 2015, and Bordeaux 2016) we have endeavoured to search the world to find and celebrate these pioneers, champions, and heroes to tell our story, as our ancestors would, to our children, to ourselves, and to the world.
Considering the actual people that our awards’ namesakes (Hippocrates, Louis Pasteur, Marie Curie, and Pedanius Dioscorides, author of De Materia Medica), their personal stories were often arduous journeys, fraught with obstacles from prevailing schools of thought and changes in the courses of their lives. Yet something within them drove them forward, a burning passion, sense of destiny, or a profound desire to help others, we can wonder. I know that they, like we, had to have the courage, vision, and commitment to imagine and to create new fields of medicine and discoveries that could help millions. Clinically, we know of the profound results we achieve with orofacial myofunctional therapy (OMT). To have such an august assembly of eminent leaders in medicine assembled here tonight and in our 2nd AAMS Congress program, along with the rising stars in research who have so passionately joined in to propel our field forward, puts a palpable sense of excitement in the air here in Chicago, and in also labs, clinics, hospitals, and homes around the world that I have been to in my work.
To deliver on that promise and excitement, however, there is so much more work to do. To actually build a field of medicine and to deliver this critical care to those who need it, and to prevent people from even developing orofacial myofunctional disorders (OMDs), will require extraordinary work. Three AAMS funding targets included in the gala program this year represent profound opportunities to deliver on that promise. The Stanford Sleep Epidemiology Research Center’s project on OMD prevalence and screening tools to identify them in large populations, the Sleep Medicine and Research Foundation’s goals to fund research in interdisciplinary care models, myofunctional therapy, and scalable, “passive myofunctional therapy,” and the Neura Institute’s project to understand the actual mechanics of OMT, as they are funded, designed, and executed upon, will help change medicine.
We are in exciting times, on the cusp of establishing a new field.